fig2
From: Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma
Figure 2. Changes in response to transarterial radioembolization over time. Response was defined as complete response (CR) or partial response (PR) using modified response evaluation criteria in solid tumors. Non-response was defined as stable disease (SD) or progressive disease (PD). Arrows depict changes in response between 3-month and 6-month imaging. The total box represents the overall count of responders and non-responders to treatment. Two patients (one responder and one non-responder) did not receive 3-month imaging, and initial response was evaluated at 6-month follow-up instead (asterisk)